SCHEMBL723679

SCHEMBL723679

N=C(N)Nc1ccccc1C(=O)Oc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.58
MAPT P10636 4/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
HTT P42858 2/20 0.58
HPGD P15428 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
CYP2C19 P33261 1/20 0.58
RECQL P46063 1/20 0.58
BLM P54132 1/20 0.58
SMAD3 P84022 1/20 0.58
PRMT1 Q99873 1/20 0.58
ACE2 Q9BYF1 1/20 0.58
LMNA P02545 3/20 0.56
ALDH1A1 P00352 3/20 0.56
USP2 O75604 1/20 0.56
CYP3A4 P08684 2/20 0.48
ITPR3 Q14573 1/20 0.48
GSTP1 P09211 1/20 0.43
ALOX12 P18054 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723680 1.00 FTO (0.58) FTOMAPTMEN1KMT2AHTT
SCHEMBL10682750 0.87 FTO (0.65) FTOMAPTMEN1KMT2AHTT
SCHEMBL726955 0.87 FTO (0.57) FTOMAPTMEN1KMT2AHTT
Hydrochloric Acid SCHEMBL1244954 0.86 FTO (0.56) FTOMAPTMEN1KMT2AHTT
SCHEMBL6232877 0.84 GSTP1 (0.57) FTOMAPTMEN1KMT2AHTT
SCHEMBL19350417 0.83 FTO (0.65) FTOMAPTMEN1KMT2AHTT
SCHEMBL9223739 0.82 FTO (0.60) FTOMAPTMEN1KMT2AHTT
SCHEMBL4142445 0.82 MAPT (0.60) FTOMAPTMEN1KMT2AHTT
SCHEMBL21194989 0.81 FTO (0.70) FTOMAPTMEN1KMT2AHTT
SCHEMBL6649726 0.80 FTO (0.72) FTOMAPTMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180251745-A1 Compositions and Methods for Modulating Hemostasis CHILDRENS HOSPITAL PHILADELPHIA (US) 2018-09-06 US disclosed
US-9896676-B2 Compositions and methods for modulating hemostasis THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2018-02-20 US disclosed
US-20160362673-A1 Compositions and Methods for Modulating Hemostasis THE CHILDREN'S HOSPITAL OF PHILADELPHIA 2016-12-15 US disclosed
US-9410137-B2 Compositions and methods for modulating hemostasis THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2016-08-09 US disclosed
EP-2431390-B1 Compositions and methods for modulating hemostasis PHILADELPHIA CHILDREN HOSPITAL (US) 2015-08-12 EP disclosed
EP-2423224-B1 Compositions and methods for modulating hemostasis PHILADELPHIA CHILDREN HOSPITAL (US) 2015-08-12 EP disclosed
EP-1948690-B1 Compositions and methods for modulating hemostasis PHILADELPHIA CHILDREN HOSPITAL (US) 2014-06-11 EP disclosed
US-20140120155-A1 Compositions and Methods for Modulating Hemostasis THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2014-05-01 US disclosed
CN-101356192-B Compositions and methods for modulating hemostasis PHILADELPHIA CHILDREN HOSPITAL 2013-09-11 CN disclosed
US-8383386-B2 Compositions and methods for modulating hemostasis THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2013-02-26 US disclosed
EP-2431389-A1 Compositions and methods for modulating hemostasis The Children's Hospital of Philadelphia (US) 2012-03-21 EP disclosed
EP-2431390-A1 Compositions and methods for modulating hemostasis The Children's Hospital of Philadelphia (US) 2012-03-21 EP disclosed
EP-2423224-A1 Compositions and methods for modulating hemostasis The Children's Hospital of Philadelphia (US) 2012-02-29 EP disclosed
US-20090175931-A1 COMPOSITIONS AND METHODS FOR MODULATING HEMOSTASIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-07-09 US disclosed
CN-101356192-A Compositions and methods for modulating hemostasis PHILADELPHIA CHILDREN HOSPITAL (US) 2009-01-28 CN disclosed